✦ LIBER ✦

A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias

✍ Scribed by Pratz, K W; Cho, E; Levis, M J; Karp, J E; Gore, S D; McDevitt, M; Stine, A; Zhao, M; Baker, S D; Carducci, M A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pharmacodynamic study of sorafenib in

✍ Pratz, K W; Cho, E; Levis, M J; Karp, J E; Gore, S D; McDevitt, M; Stine, A; Zha 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 441 KB

Phase II study of sorafenib in patients

✍ Anna Guidetti; Carmelo Carlo-Stella; Silvia L. Locatelli; Walter Malorni; Marina 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

4-Demethoxydaunorubicin (Idarubicin) in

✍ Angelo M. Carella; Gino Santini; Marina Martinengo; Domenico Giordano; Sandro Na 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

A phase I and pharmacodynamic study of s

✍ Brenda W Cooper; Erin Donaher; Hillard M Lazarus; Sylvan B Green; David M Gosky; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 863 KB

Treatment of patients with acute nonlymp

✍ Dr. J. Goldberg; H. Grunwald; W. R. Vogler; E. Winton; G. Browman; I. Walker; A. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Daunorubicin in patients with relapsed a

✍ T. Velu; L. Debusscher; P. Stryckmans 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views